Presentation to include clinical data from Aronora's phase 2 study of AB002, a first-in-class protein C activator enzyme that is being developed for the treatment and prevention of thrombotic and inflammatory diseases.

Enzyme that selectively targets blood clots has received FDA Fast Track designation, allowing for expedited clinical development

For people taking blood thinners, including aspirin and warfarin, the risk of an invasive procedure is a serious concern. Guidelines authored by Dr. Steven Miller, a Chicago-area podiatrist, will help doctors who perform foot and ankle surgery tackle this important subject.

Xarelto may cause irreversible internal bleeding that can lead to hospitalization and death. What are the risks?